Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice $NDTP TA and share data history for 2023 sir, thanks for accumulating it and sharing it.
I am in another stock with same TA #1 and TA #2 and TA #3 history that is just as crazy. Might be worthwhile to add who the TA's were on each report to your data list?
It has caused, is causing even more of a stir on that one than NDTP (Because in part it was trading with 100% incorrect TA SS data the last 6 months). And that makes me wonder how many others there are. When I checked there were 100's of firms the TA #1 had as clients that TA #2 took over for. Many were SEC / Nasdaq, not just OTC stocks...
I'm disgusted!
Take a look at this list. i hold the top 6 men on this list responsible for this debaucle. These are the 5% material owners of NDTP, and not one of them is an advocate for common shareholders. They do nothing while this once promising company gets crushed by a corrupt shell custodian CEO who does nothing to get us in good standing with OTC Markets, and abjectly refuses to communicate with us. We are fly shite to him. This as he enriches himself by 42 million shares to cover a puny $5k expense reimbursement.
This cannot happen without the tacit approval of the other 5 5% material owners on this list. They are the ones who gave Passalaqua the one super majority share which crowned him king and allowed him to gift himself enough shares to become the top insider. You must hate your own company to do such a thing. Shame on all 5 of them.
Passalaqua should be arrested for larceny of our company treasury. I am 100% off the bid on this. As many of you know i spent the better part of 6 months on the bid at 10 cents to protect our price and in the process picked up another 15 to 20k shares for peanuts through my Canadian trading account. I'm one of the very few who can buy as much of this as i can stomach. And i'm done so now someone is on the bid at .0009. Not until Passalaqua is gone or in cuffs and a material insider comes out and apologizes to us for the last two+ years will i return.
Rest in pieces NDTP. You had so much promise and now under the "leadership" of these 6 men things have never looked so grim.
Note: We might need to add William Burton to our 5% insider list as there are claims in the most recent filings that he purchased enough shares from other insiders through private sales to jump above the 5% threshhold, so that makes 7 material insiders destroying this company. Great investment Willy. No sooner did you buy your shares than King Joseph the First stole 42 million shares at a valuation of .000123. Bet you didn't get the King's valuation on those shares you bought? But maybe i'm wrong and the grift and rot extends throughout the top 7.
46,000,000 Common Joseph Passalaqua 28.75%
39,600,000 Common James Hovis 24.75%
21,600,000 Common Edward Mathias 13.50%
16,200,000 Common Lawrence Kubin 10.12%
14,040,000 Common Stuart Yarbrough 8.77%
12,960,000 Common John Morrissey 8.10%
4,545,000 Common William Burton 2.84%
1,080,000 Common Mark Alarie .67%
925,000 Common John Munoz .58%
925,000 Common David Ambrose .58%
925,000 Common Robert Kirk .58%
900,000 Common Kevin Malloy .56%
304,349 Common Old MILV Shares .19%
160,004,349 TOTAL
Yeah I haven't been keeping up with this much, but still own shares so hopefully something comes here one day.
Lol…………..
1/10/23 TA no longer verified
1/24/23 TA verified
2/13/23 ss update
Old 117 mil
New 273 mil
2/22/23 ss update
Old 273 mil
New 476k
3/13/23 ss update
Old 476k
New 273 mil
3/22/23 shell status removed
4/11/23 ss update
Old 273 mil
New 160mil
5/17/23 pink current (CE)
6/8/23 ss update
Old 160mil
New 476k
6/27/23 ta no longer verified
6/27/23 ss update
Old 475k
New 160mil
Thanks for the update. At this point we have no idea what the SS actually is. It has gone back and forth between 160mil and 476k a few times now and has also showed a few different TA’s over the course of the past few months.
I did notice that just before the update you posted, the TA went to unverified. So TA goes unverified and then about a half hour later the SS went back to 160mil.
Did it revert back to that SS only because TA is unverified? Who knows lol,
$NDTP
— OTC Updates (@OtcUpdates) June 27, 2023
💰0.9900
💀, Pink Current, AS: 1.1B, OS: 476K, US: 292K
🔴Transfer Agent is no longer Verified...
Full Details: https://t.co/01McTD4meB
https://t.me/otcupdates/51376
159 mill added to restricted
Well if the Original Insiders, that ran 3 different top gun NYSE / Nasdaq firms are still restricted share holders, with this CEO being their place holder since Hovis was sidelined for life IMO, they will find replacements, just like they Found the two nano Liposome Genius people spanning the last 40 years that invented and research this, and this kind of, tech that NDTP has,and then find a real Nasdaq skilled level quality CEO to bring in with serious cash and maybe a Licensee or deliverable product customer(s) (I have one in mind) to get us the road finally..
For now I loving the huge TA reported share changes. Assuming they are legit. BTW, that may be delaying removal of the CE, as OTC will want to see filings explaining it first..
Prior CEO did not want the CE off yet IMO. Then In Aug 2022 Dr, Mark Kester died.
So they had a likely brain damaged by strokes, Hovis now ex CEO to replace, then Kester died, then it was a punt and likely a who has enough vote shares to pick an interim CEO, while the original problem gets fixed or a new plan is put together... As long as the CE stays on insiders are trapped giving time to build a real business to value the company. The current CEO is not a Bio-tech drug guy, just an interim experienced shell reviver and handler is too old now for this stuff (77?) IMO..
If the share structure is truly under 500K now, I am as happy as pig in mud, even with the CE for now.
Lets give them time to find a replacement for Dr. Mark Kester, and Nasdaq caliber CEO and viable plan, either the NDT platform or it and a second item like a deliverable for the delivery NDT Particle complex...
The Pandemic and a death, and bran damaged (I assume from the strokes ex-ceo) delayed everything.
I bought A $10 stock with an 11% dividend that looked safe, and it is under $2 now with no dividend thanks to the FED, so my shares of NDTP are looking way better right now than many Nasdaq stocks.
I think they need time to replace the people they lost to the Pandemic.
It is Pink Current now for the first time in ages. And if the TA is right, we have a share structure to die for now.
We waited this long, and we are closer than before as far as reporting and Pink current wise.
They do need a working website, they may be the CE hold up, and they may be keeping the website dark, until they have real Nasdaq skilled Bio-tech CEO and Dr. Kester replacement.
That’s what I am thinking. That OTC markets has it out for leadership. I’m in another Passalaqua custodian play (QOIL). We have been CE for a while now with crowdfundings every year but no other news. It’s wild. Good luck guys….
Hold the fort. The TA is back to monthly updates. Last one was June 12, the second Monday of the month.
At this point it might take audited financials. Clearly this leadership team of one has lost most or all credibility with OTC Markets. Up hill slog. Doesn't help that Passalaqua changes the share structure more often than Pedo Pete's diapers.
What does it take to get the CE removed? It’s insane they keep filing these attorney letters but it seems as if OTC Markets could care less and has it out for them. Anyone?
This is a third (new) TA now, so they may not have accurate data yet, like the last one (fiasco).
So lets see if anything changes this month.
This sounds positive news!
This TA has now moved to updating the NDTP share structure every day, just like the IFUS TA does.
Before this latest update this TA was only updating NDTP once a month, usually the first or second Friday of each month.
I like the daily TA updates. We will need to check it on a more regular basis.
Please do not jump to conclusions. 1) NDTP is not a shell, and 2) it does have assets.
Enough with that BS.
What the assets are worth is another matter, to be determined.
If the CE is dropped, we do not know who owns the restricted shares, But there are not enough now, if they are unrestricted, to hurt us.
We got what we wanted. Now we need to see who still has shares. All the founder insiders could still be here, with preferred shares instead? Or with about as many shares as we have, just less.
Lets see what they do next... This is a huge step forward. It may be the step to enable bringing in cash, and an experienced CEO in the nano Tech drug or drink, or both world.
Since retail now owns about 2/3rds of the OS, lets see what they do next.
This has restored my faith here... We stopped the shenanigans.
I go even further...Holy Shit!
Now for the interesting part: speculation! WTF does this all mean? We are a clean shell with no assets inside it, ready for R/M with a real company that might do something?
And, what would be the value of the R/M? Can a company BUY NDTP, and we finally realize some $$$ for our shares???
Inquiring minds want to know......
Holy cr@p just saw the OTC Markets update to the NDTP share structure as of 6/7/23 and we are back to 476,899 outstanding shares.
All insider shares are gone apparently. The unrestricted float is unchanged at 292,164, with the restricted shares at 184,735.
Rock on NDTP!
https://www.otcmarkets.com/stock/NDTP/security
I know some have said that this issue of a super share is NOT that uncommon for corporations. Many wish to keep control and not let wild shareholder issues get traction to the detriment of the corporation. I understand this.
However!!!!! The dangers of this super share, as Chasedog has so well stated, shows us the potential abuse that can happen in such a situation. We see it in the latest filing.
Its unconscionable that a $5000 expense could be taken as a 40 Million share "gift" - and no one can do anything about it. Should this issue NDTP, get out of CE HELL, this represents a $200 MILLION payday at the previously $5 a share price.
Wish I could spend $5000 and get $200,000,000. Not even bank robbers can do as well.
Unfortunately, the super vote carries with it an additional 300 Million votes so that NO ONE, I repeat, NO ONE can over ride whatever this CEO wants.
The time is rapidly approaching where LEGAL ACTION is warranted to wrest control back to us so that we can make this company actually perform. I believe PUNATIVE DAMAGES are also in order.
This house needs to get itself in order and FAST!
The 29,600,000 Hovis shares were a typo. He owns 39,600,000 shares. More amateur hour.
The breakdown of the insider sales to other insiders that were part of the 1st quarter filing that i printed off two days ago is gone. That paragraph i copy and pasted about Burton's now 11 million shares is gone. I can't find it. What the heck is going on here?
Lastly, don't forget the other insiders thought so highly of NDTP's technology and value, that they gifted 1 super V voting share to the shell custodian that effectively wiped out any and all say about the direction of this company for them. They self-nullified control. And i have found nothing in this filing that mentioned any value received for gifting this super voting share. Meaning it was a freebie. In essence, if he had wanted to he could have gifted himself another 964,995,651 shares, bringing the total outstanding up to the authorized limit of 1.125 billion shares. And there isn't a thing the other insiders could do about it. Tells me they've moved on, and Passalaqua knows it. Maybe the next time Passalaqua changes the toner in the copier he'll reimburse himself the remaining 965 million shares at .000000000000000000123 per share. If you're keeping score at home that's 18 zeroes.
The abject insanity of it all is mind blowing. It has to be criminal.
Most of the almost 300,000 shares in the public float were purchased at between $4 and $5 over the year after the reverse split. A few shares went for $11+ each, meaning we spent a combined $1.3 million for just a third of a million shares. And this man has the gall to take 42 million shares for a $5,000 expense reimbursement. OTC Markets and the SEC need to know what is happening here. It is their job to protect us from predators like Joseph Passalaqua.
Heck of a good point, drugman. It does appear as if the insiders value the CCA tech at less than zero, making it worthless. That means the first reverse split might possibly have been a scam. And we know the proposed second reverse split was a scam. Thankfully enough common float investors came together to kill that horrible deal.
Passalaqua should take my hundred K offer, take the CCA tech that he and the insiders believe is worthless with them, return the 159,700,000 restricted shares to the company treasury, and let's build a super profitable company with under 5 million total outstanding shares. With such a small share structure the stock price could soar into the hundreds.
This ticker badly needs someone at the helm that respects the shareholders who have been loyal long-term investors.
We tracked down the original CCA NPC to Hovis in 2007, and Dr. Michael Fountain in in 2007 and then in 2010 at Univ of So. Florida, with 4 Federal agencies funding the 2010 R&D.
Then in 2013 Hovis, Fountain and the CCA founders all started working with UPennMed Med on TBI project (clearly documented, to some extent in the 2010 University paper Fountain co-authored) in a JV.
It is possible the CCA/UPennMed NPC was going to used the Dr. Mark Kester's Ceramide Phase III approved Cancer trial that was approved in late 2019, as the time of the take over the shell, now NDTP, was the same week Keystone Nano got the FDA Phase III approval and the day Keystone went dark on news and social Media..
The key problem here is this CEO and the Founders/Insiders are not acting like their shares are worth more than .0001 based on this clown-CEO's resent self serving actions
gifting himself 40 Million shares.
And they have no working website. WTF is that all about?
The last clown act on the cook books (IMO) deal was so obvious that it brings doubt as to the value or motives of the person in control and who ever gave him that control.
Public companies are required to be transparent. And real 3rd grade math skills are also important. But have been missing here at times requiring filing corrections.
Last year I wrote it off to Hovis's health issues. 2020-2022 I wrote the delays off to Covid19, that seemed obvious, and then July 2022, the death of Mark Kester was huge set back.
But the recent failed plan and attempt to apparently cook the books with what looked like an obvious overseas cook the book and up list to Nasdaq plan from the EU (The Kind figured out and stopped before, scams) R/M for barely out of the cradle drug trials, that would needs 100's of millions of dollars for 5-10 years of cash burn, while generating no revenue, plan to wipe us out with second R/S of 100:1 after a 1000:1 R/S is simply unethical white collar crime at the highest level, with no sign of anyone exhibiting any fiduciary responsibility here except the retail shareholders.
Let's look at what is right in front of us.
The company was set to pay 15 million dollars to Coretag to have Coretag take the ticker off Joe's hands and dilute current shareholders 25 to 1.
Telling shareholders that the CCA technology in hand is considered 15 million dollars less then worthless.
What an interesting Ponzi Scheme.
Here you have Coretg Holding owning two Subsidiaries. Coretg Theraoeutics AG and Actinocore GMBH.
Coretg Holdings transferred all its license and intellectual properties based on its proprietary
NTPT for the development of its targeted radiotherapy to Actinocore GmbH,
Based on what is in the filings Coretg Theraoeutics AG has nothing of value.
So we have one subsidiary Coretg Theraoeutics AG of Coretg Holding signing a deal with Coretg Holding to acquire Coretg Holding other subsidiary Actinocore GmbH,.
NDTP is acquiring Coretg Theraoeutics AG .for 100,000 share of 25-1 post split stock.
Once Coretg Theraoeutics AG .is acquired, NDTP will pay Coretg Holding additional Common Stock Post Reverse Split in the Company as the additional purchase price for the acquisition
of the Licensee Company by the Target Company at a valuation of One ($1.00) US Dollar per shares in
accordance with the Valuation Report (One Hundred Million ($100,000,000.00) and Four Hundred Million ($400,000,000.00 or 100,000,000 to 400,000,0000 shares) so that Cortg holding subsidiary Coretg Therapeutics AG can purchase Cortg holding subsidiary Actinocore GmbH.
In addition Fifteen Million ($15,000,000.00) US Dollars will be paid by the Company in cash to Coretag Holding when the Company is funded and whereby the Coretag Holding will become the control shareholder(s) in the Company,
So in the end Cortg Holding ends up with NDTP while still controlling both its subsidiaries and being 15 million richer while NDTP shareholders get screwed with a 25 to 1 reverse split and 100,000,000 to 400,000,000 shares of dilutions and having NDTP fronting the bill so that Cortg Therapeutics AG can purchase Actinocore GmbH. .
I echo your concerns!
I sure would like to know what we have here and as a shareholder/owner of the company Its CRIMINAL not to be INFORMED!
Well the latest fillings are not what I expected, and beyond what I already posted last night about the share structure of the Insiders share, etc,
I also want proof of the claim that we do indeed own the UPennMed side of NPC JV technology know how and IP, Details on what it is (short of releasing any confidential IP secrets),and not just the Hovis/Fountain/NPC tech dating back to 2007, 2010 and 2013 and 2016.. part or do we truly own all of the CCA/UPennMed R&D. And what is it????? What/where are the studies and results?
We do not know from NDTP (all though I have solid clues of my own from my own DD, that I am not ready to disclose here) what else they have planned and on the serving table to bring in once the CE gone. If we knew what the plan was, and saw proof this about to be a Billion dollar firm, once the CE was gone and updates were added, I might not be raising so much hell.
After all they did bring us Dr. Mark Kester, who was a genius in the top of the NPC field, but he was not a UPennMed guy, he was from the University Kubin graduated from IIRC.
With Him on Board, I was, at the time willing to chill on the original Insiders share count.
But the filings this year, cast doubt, and suggest we got ripped off on the R/S and following mass out of control printing of shares, for what?????
Hovis never should have issued so many restricted shares, and neither should this CEO, IMO.
Count me IN!!!!
For all we know. CCA may have funded a grad student's summer research project (related to liposomes?) some years ago (with the requisite IP right-of-ownership assigned to CCA). If anyone wants to see substantive examples of funded research, a web-search using terms like
"sponsored research agreement" <space> 'university-of-pennsylvania"
can dredge up dozens of public records in company PRs, SEC filings & various universitys' (not just UP but Yale for example) departments & procedures that provide the kind of details completely lacking in the copy-and-paste text used to repeatedly populate NDT's filings and will-o'-the-wisp websites.
I agree that there has been more than enough time for any real/current activity related to what NDT purports to do to be revealed. Recent events (the recently aborted reverse-merger) imply more that this is nothing now beyond a public listing that can potentially be sold to an entity looking for an entry into the US market without an IPO. That's not nothing, but you gotta have faith that whoever's up in the cockpit knows how to fly the thing.
I look forward to events proving my guesses to be completely wrong.
I can't make heads nor tails out of the numbers supplied in this attorneys letter. The number of mistakes and typos is pure amateur hour. Where to begin?
Here were the 1st quarter share breakdown of insiders. Keep in mind this was as of 3/31/23
46,000,000 Common Joseph Passalaqua 28.75%
39,600,000 Common James Hovis 24.76%
21,600,000 Common Edward Mathias 13.50%
16,200,000 Common Lawrence Kubin 10.12%
14,040,000 Common Stuart Yarbrough 8.77%
12,960,000 Common John Morrissey 8.10%
4,545,000 Common William Burton 2.84%
1,080,000 Common Mark Alarie .67%
925,000 Common John Munoz .58%
925,000 Common David Ambrose .58%
925,000 Common Robert Kirk .58%
900,000 Common Kevin Malloy .56%
304,349 Common MILV .19%
160,004,349 TOTAL
In the attorneys letter it states there were private transactions made by insiders who bought shares from other insiders from around the May to June, 2022 dates. So these transactions happened 9+ months before the Q1 financials were released, yet were not included in the Q1 report. Amateur hour.
Hovis' shares dropped from 39.6 million to 29.6 million. Where did the 10 million shares go?
Mathias' shares dropped from 21.6 to 17.6 million shares. Where did the 4 million shares go? 2 million look like they went to Burton.
Kubin's shares dropped from 16.2 to 15.2 million shares. where did the 1 million go? 500,000 appear to have been bought by Burton.
Yarbrough from 14.04 to 13.04 million shares.
Morrissey is the only one who sat this clown show out. He stayed steady at 12.96 million shares.
And the big winner, or loser perhaps, is Burton who apparently bought or attained an extra 6.5 million shares to up his total to over 11 million shares. Burton could be our Huckleberry. If he was buying shares for real money only 9 months ago then he must have felt this company had real potential. He might be the most pizzed at Passalaqua for effectively gifting himself 42+ million shares to cover a $5k reimbursement. Let's start with him.
William H. Burton
SCI Inc.
1067 E US Highway 24
Woodland Park, CO 80863
We vetted some or all of these insiders, and guys like 2-time Super Bowl participant, Kubin, and former Duke All-American, Alarie, appeared to be solid. But this has turned out to be scammy as heck, and i'm wondering how these other insiders are allowing first Hovis, and now Passalaqua, to screw the 292k puny public float holders over like this.
This can't be allowed to continue. The attorney's letter is full of mistakes and outright lies. We should offer $100 grand for the shell, take your "tech" with you, return the 160 million insider shares to the treasury, keep and protect the 292,164 unrestricted float shares, and keep and protect the 304,349 old MILV shareholdres that amazingly are still holding restricted shares. I'd be in support of freeing up those shares and unlocking them into the public float. It's time they had the freedom to sell or stay. Bring in new management with fresh ideas and throw 3 to 5 million restricted shares max at them and we've got a super low outstanding share count company that could really fly with profits. How would you like to have a company with 596,513 shares in the float and say 4 million restricted shares for a total outstanding of 4,596,513 shares? Think we could make that work? And have less than 5 million shares outstanding! And run by people who understand their fiduciary responsibility to shareholders. And who communicate with said shareholders.
I have a fabulous idea for a company in a super hot industry right now that we could just blow up. It's not in pharmaceuticals so we'd need a name change. But i won't talk about it until i know the insiders could be convinced to walk away. Otherwise it's a giant waste of time.
Did you guys see this:
There are now 7 insiders who own 5% or more of the NDTP common. Burton upped his stake to over 11 million shares by buying existing shares from other insiders. Before June of last year he owned 4.545 million shares.
William H. Burton is a greater-than-5% beneficial shareholder of the Issuer, and his
business address is 1067 E US Highway 24, Woodland Park, Colorado, 80863. As of
May 17, 2023, Mr. Burton beneficially owns 11,095,000 shares of Issuer common stock
held in the name of his entity, SCI Inc., consisting of (a) 1,075,000 shares of Issuer
common stock issued by the Issuer on or about September 30, 2020, and 2,520,000
shares issued by the Issuer on or about November 19, 2020, and all of which shares
were issued in consideration of the shareholder’s conversions of shares of the Issuer’s
preferred stock (which shares of preferred stock had been issued in consideration of the
Asset Acquisition) into common stock; and (b) 7,500,000 shares of Issuer common
stock, which were not new issuances by the Issuer, but which were acquired by the
shareholder in private sale purchases from other insiders identified herein as follows:
5,000,000 shares from CCA on or about June 8, 2022, 500,000 shares from Lawrence
Kubin on or about June 15, 2022, and 2,000,000 from Edward Mathias on or about
June 15, 2022. All 11,095,000 of such shares were issued with a Restrictive Legend
Nope.
1) Where is the proof of this claim from UPennMed?
"NDT Pharmaceuticals, Inc has acquired all rights under a Sponsored Research Agreement with the University of Pennsylvania, including rights to use the University's NPC technology and Intellectual Property."
Show us proof, before OTC Markets even considers the lifting of CE.
Then show us what the UPennMed "University's NPC technology and Intellectual Property" actually is?
On UPennMed paper work.
What is it worth? What can it be worth?
Right Now I do not trust the less than 5% insiders not to dump shares once the CE is gone. Or shorts not to murder the value retail spent 3 Million dollars building up in NDTP since 2020.
Right now all the Insiders shares seem to be 1000x over issued in volume and or 1000X overvalued, and issued after retail got a 1000X hair cut. Looks like white collar crime to me, smells like white collar crime, and I am sure a jury would agree.
Retail supported the share price at up $10.90/share while it was allowed to have bid support, to the tune of 3 Million dollars invested in the retail shares since it became NDTP.
It is not retails fault the share price fell.
2) They do not even have a website now?
https://www.ndtpharmaceuticals.com/
Agreed. If Passalaqua was able to issue himself 42 million shares at .000123, that leads me to believe the insiders couldn’t care less about this failed endeavor.
Therefore, “The Company is now focused on developing products to utilizing the intellectual property described above.” taken from OTCMarkets, which was verified today, is complete BS.
Let’s see some transparency Passalaqua
This NDTP CEO, Pasa.... who steals shares like a fox guarding the hen house,
needs to go and return those ill gotten free shares, return all those shares, before I contact the IRS, the SEC, the FBI, and every federal agency there is and throw the book at him/them as a side dish with law suits?
In other words, I am done playing games here.
OTC markets needs to keep that CE on here until we get a full disclosure on everything they are hiding. We have plenty of public proof of tom foolery here now.
Logic is not disclosure.
Now if by some miracle, this CEO R/S the insiders shares 95+% including this CEO's shares, since they have not proved they have delivered anything of real value in 3.5 years, and leave the retail shares they already R/S 1000:1 alone, and then bring in something of real value, like a Real pedigreed drug firm CEO, with a real revenue producing product, with real revenue, I might chill out and do a happy dance. But it all needs to be priced not on the basis of .001 to .0001 share gifts, it must be priced on the basis of retail trade prices this stock traded at, Up to $10.90/share, after retail was R/S 1000:1 by Hovis/Pasa CEO tag team, before Hovis went nuts printing shares at .001 and diluting retail a second time, for what he later said in filings, said he could not prove or claim had any value?
If it had no value why bother???? It can not be both worth a billion dollars and worthless at the same time.
If it is worthless all the insiders need to do is sell us their shares for .0001, the value this current CEO placed on the shares he gifted himself, and solve their problems, and we could return them to the treasury in a friendly take over?
One has to wonder if some of the insiders might join us in suing this CEO(?), and help us remove this guy and his ill gotten shares, if he refuses to act responsibly?
Or force him to act like a responsible Public CEO who acts in the best interest of shareholders. It is called fiduciary duty.
I see a laundry list of BS in the financials I will raise hell about and document this weekend when I have time.
One can not have a list of the Over 5% insider shareholders add up to 102% of the OS and leave out the insiders that have less than 5%, and claim that adds up to 100%. Read top of page 10 out 22 pages of the brand new quarterly pdf.
I doubt OTC markets lets this Q filing pass the smell test... with obvious errors like that.
And today I here an attorney letter was filed? Does no one do real math any more? Does no one read and check this stuff anymore?
My instinct tells me the insiders all gave up, or 2-3 larger insider shareholders made a bad choice, and / or this CEO is trying to screw us all?
Either that or they are just as mad as retail and might join us in a law suit?
There is zero legitimate excuse for the BS this CEO pulled.
Something is rotten in Denmark.
If the founding insiders gave a damn about the company, they would be willing to sue him also, if needed, or they would have supplied the cash needed themselves, if this company had anything of value, they would not have allowed him to do this BS, mass printing of basically free shares to himself.
Retail's 3 Million dollars invested here, is not going away. I even wonder now, just how much CCA, LLC ever actually invested (sunk costs, in the JV study at UPennMed?) That was never publicly disclosed.
So I repeat, Mr. CEO, if NDTP has anything of real value, act like it, and prove it, and if not you and the insiders need drop your share count about 95% and get out of the way and let a retail group bring in some solid, High value tech here.
No credible company manager, public or private, especially in the nano tech-Bio-Tech world would touch this company with this share structure, and the current retail folks will not submit to further abuse....
Removing the CE now, would destroy retail shareholder value as Wall Street shorts would use the restricted shares to print massive naked short shares and destroy the stock.
How in the world did the major insiders, like Edward Mathias, the second largest shareholder, et al, let this BS get this far?
So either do the right things, do them now, or ...... Is where I and the retail shareholders are at right now.
OTC Markets has plenty of legitimate reason right in the filings and flip flops, and lack of information in the filings, to hold this in CE land until we get answers and full disclosure.
Public companies have a duty to disclose everything.
CEO's have a fiduciary duty, to not rip off shareholders, just because they can.. and frankly the control group insiders put this guy in the position he is in. Retail did not put in office.
If the tech has no provable value yet, then all the restricted shares should R/S to reasonable size, and then make this a solid Nasdaq Quality company with high value tech.
Hovis in his original filings and earlier this year, this CEO, claimed in earlier filings this year, the tech may not be viable, so how does that justify issuing 1/2 to 1 Billion dollars of shares at ..001 to .0001 to insiders, (To avoid income taxes?) or because the tech is worthless??
Either prove it is worth a billion dollars, or execute 95-98% of the insider shares and CEO shares and lets find a private tech ready for Nasdaq??
They have posted similar letters before to OTCMARKETS and nothing was changed.
Lets hope OTCMARKETS gets their act together and removes the CE status once and for all this time.
I look forward to this issue finally being able to freely trade.
NDTP has $142 thousand in accounts receivable. That means we have revenue coming in at some point soon perhaps. So Passalaqua could have waited for that to arrive for his $5k expense reimbursement. A little patience would have saved the company treasury around 40 million shares.
Does he seem like a good, fair, and honest steward of NDTP performing his mandated fiduciary responsibilities to protect all his shareholders, both restricted and unrestricted? Or is this just a giant share grab to make himself numero uno, super V or not?
Smelly with a tinge of rancid.
So... I'll address this to the board of directors:
You've got all these millions of shares. Good for you. Right now this issue isn't trading. So your shares are worth ABOUT zero. You want some $$$??? You've got to get this issue trading without the CE.
So unless you like having a piece of paper with fancy printing on it that says you own millions of shares in a company, and nothing more, get off your A$$ and get this issue trading properly without restrictions of a CE.
NOT HAPPY!
Passalaqua just gifted himself enough shares so that he's the new big dog. And all the original members of the Beattles are back with their shares fully intact.
Passalaqua also somehow rounded up his number of total shares to 46,000,000 exactly. Funny how those pesky reimbursed expenses for 42 million+ shares worked out just perfect to round up his total to the nearest round million?
This is super smelly, like month old fish in a folded newspaper. Here's our updated roster and ownership percentages:
46,000,000 Common Joseph Passalaqua 28.75%
39,600,000 Common James Hovis 24.76%
21,600,000 Common Edward Mathias 13.50%
16,200,000 Common Lawrence Kubin 10.12%
14,040,000 Common Stuart Yarbrough 8.77%
12,960,000 Common John Morrissey 8.10%
4,545,000 Common William Burton 2.84%
1,080,000 Common Mark Alarie .67%
925,000 Common John Munoz .58%
925,000 Common David Ambrose .58%
925,000 Common Robert Kirk .58%
900,000 Common Kevin Malloy .56%
304,349 Common MILV .19%
160,004,349 TOTAL
I know I'd be moving my d$$$ a$$ night and day to remove the CE if I was looking at $200m-400m payday. I couldn't work fast enough to get it done.
WTF is he taking so long????
WOW! His 42mil shares will be worth $200-400 Mil when NDTP goes back up to last 2 years' $5-10 range. @$50, $1Bil+.
What a Bonus!
Yes and he paid less than .000125 per share to pay of a 5k debt.
They are under rule 144. The company was not current at the time that they were issued so he would need to hold at least a year if I am reading it correctly.
https://www.sec.gov/reportspubs/investor-publications/investorpubsrule144
@0.10, that should be about 51k shares only?
How did he pay himself more than other insiders?
Seems a bit criminal id say.
AT 10 cents a share, looks like a real bargain.
42,127,450 shares x 10 cents a share = $4.2 M dollars +
Wish I could of spent $5k for that.
Hey Passalaqua, I’ll pay off that $5182 debt in exchange for those 42,127,450 shares you received for payment. Where should I send the check?
In the report they say that they "are a going concern" . Shouldn't OTCMARKETS now remove the CE???
Latest 1st Q results are in !
https://www.otcmarkets.com/otcapi/company/financial-report/371737/content
I think $NDTP broke the OTC Markets record book for the highest share prices, for the longest time as a CE stock the OTC markets ever saw.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |